Valinor Discovery uses machine learning to simulate drug performance and support data-driven drug development decisions.
Valinor Discovery has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Valinor Discovery's investors include CRV, Harpoon, Pelion Venture Partners, Kickstart, Charlie Songhurst.
Valinor Discovery is headquartered in San Francisco, United States.
Valinor Discovery uses machine learning to simulate drug performance and support data-driven drug development decisions.
Valinor Discovery is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Valinor Discovery — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/valinor-discovery. Accessed July 25, 2026.
VCBacked. (2025). Valinor Discovery — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/valinor-discovery
{{cite web |title=Valinor Discovery — Funding & Investors |url=https://www.vcbacked.co/company/valinor-discovery |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated